Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

Generating specific cell lineages from induced pluripotent stem cells and embryonic stem cells is the holy grail of regenerative medicine. Guiding iPSCs toward a target cell line has garnered much ...